Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma
Clinical trial NCT02938728 · UNKNOWN
Trial details
- NCT number
- NCT02938728
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-11-01
- Primary completion
- 2020-03-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.